Connect Biopharma Holdings Limited (CNTB) Stock price, Description, News & Info

#ThinkSabio Latest News

Connect Biopharma’s Exclusive Licensee in China, Simcere Pharmaceutical, Announced Submission of its New Drug Application for Rademikibart for the Treatment of Atopic Dermatitis in China